跳至主要内容
临床试验/EUCTR2014-004758-33-AT
EUCTR2014-004758-33-AT进行中(未招募)1 期

Randomized Assessment of patients with clinically suspected Prostate cancer after multiparametric metabolic hybrid Imaging to evaluate its potential clinical Domain: A prospective, randomized, multi-arm, multi-treatment clinical trial - The Rapid study

Medical University of Vienna0 个研究点目标入组 220 人开始时间: 2015年3月4日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Clinical suspicion of prostate cancer:
  • blood PSA level > 4.0 ng/ml and/or
  • free-to-total PSA ratio <22% and/or
  • progressive rise of PSA levels in two consecutive blood samples despite antibiotics
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 55
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 165

排除标准

  • antiandrogen therapy
  • prostate needle biopsy <21 days before PET/MRI
  • known active secondary cancer
  • endorectal coil not applicable (e.g. anus praetor with short rectal stump)
  • known active prostatitis (e.g. painful DRE)
  • known anaphylaxis against gadolinium-DTPA
  • patient’s written informed consent not given

研究者

相似试验